Form D · Manufacturing

GVB Biopharma

Las Vegas, NV · CIK 0001809889

Offering snapshot reported May 19, 2022 · SEC filing

Reported sold
$1M
Offering amount: $1M
Investors reported
1
Form D · investor count
Minimum accepted
$50K
Reported outside-investor minimum
First sale
Apr 18, 2022
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 19, 2022Initial$1,000,000No comparison1SEC filing
Jan 19, 2022Initial$1,750,000No comparison2SEC filing
Nov 3, 2021Initial$1,500,000No comparison10SEC filing
Nov 27, 2020Initial$7,606,500No comparison28SEC filing
May 27, 2020Initial$1,250,000No comparison1SEC filing
Apr 16, 2020Initial$450,000No comparison4SEC filing

Offering details

Securities
Debt, Option to acquire
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$100K
Finders' fees
$0
Form D file number
021-446206

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
TerraNova Capital Equities, Inc.45097

Source: Form D, filed May 19, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jack Feldman Director, Executive
William Spiegel Director, Executive
Theodore Swindells Director
Phillip Swindells Director, Executive

Issuer details

Industry: Manufacturing (See others in industry)

Address:
4456 E. Craig Rd.
Las Vegas, NV, 89115